Evidence map›Paper›PMID 27590297›Full record

ArticleBMC neurology2016

Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

Flora M Hammond, David N Alexander, Andrew J Cutler, Stephen D'Amico, Rachelle S Doody, William Sauve, Richard D Zorowitz, Charles S Davis, Paul Shin, Fred Ledon and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Flora M HammondPhysical Medicine and Rehabilitation, Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 4141 Shore Drive, Indianapolis, IN, 46254, USA. Flora.hammond@rhin.com.
David N AlexanderUniversity of California, Los Angeles, CA, USA.
Andrew J CutlerFlorida Clinical Research Center, LLC, Bradenton, FL, USA.
Stephen D'AmicoCornerstone Medical Group, Franklin, TN, USA.
Rachelle S DoodyBaylor College of Medicine, Houston, TX, USA.
William SauveTMS NeuroHealth Centers, Richmond, VA, USA.
Richard D ZorowitzMedStar National Rehabilitation Network, Washington, DC, USA.
Charles S DavisCSD Biostatistics, Inc., Tucson, AZ, USA.
Paul ShinAvanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Fred LedonAvanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Charles YonanAvanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Andrea E FormellaAvanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Joao SiffertAvanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27590297
PMCPMC5010732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.